Research Output per year
Personal profile
Teaching
Biography
Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at Ninewells Hospital and Medical School, Dundee, United Kingdom. He trained in both cardiology and clinical pharmacology in the United Kingdom and in the United States where he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville and a Fulbright Scholar at Columbia University, New York. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh and the American College of Cardiology.
Research
His research takes a multi-disciplinary approach to the understanding of the pathophysiology and pharmacogenetics of cardiovascular diseases and to the development of treatment strategies in patients with cardiovascular diseases. He leads an integrated cardiovascular research laboratory dedicated and equipped to the study of cardiac and vasomotor regulation. These techniques are applied towards translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. Prof Lang is the Work Package Lead for the validation cohort for the FP-7 funded BIOSTAT-CHF study that aims optimize the treatment of heart failure for each individual using information from genomics and proteomics. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, Chest Heart and Stroke Scotland, Tenovus and the European commission Seventh Framework Programme (FP-7) funds his research.
Education/Academic qualification
Doctor of Medicine, University of Dundee
Bachelor of Medicine and Bachelor of Surgery, University of Dundee
Bachelor of Science, University of Dundee
Keywords
- RM Therapeutics. Pharmacology
- Cardiology
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 39 Similar Profiles
Heart Failure
Medicine & Life Sciences
Brain Natriuretic Peptide
Medicine & Life Sciences
Atrial Natriuretic Factor
Medicine & Life Sciences
Kidney
Medicine & Life Sciences
Angiotensin-Converting Enzyme Inhibitors
Medicine & Life Sciences
Mortality
Medicine & Life Sciences
Exercise
Medicine & Life Sciences
Blood Pressure
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1985 2018
A Randomised Controlled Trial of a Facilitated Home-Based Rehabilitation Intervention in Patients with Heart Failure with Preserved Ejection Fraction and their Caregivers: The REACH-HFpEF Pilot Study
REACH-HF, 9 Apr 2018, In : BMJ Open. 8, 4, p. e019649 12 p., e019649.Research output: Contribution to journal › Article
Open Access
File
Caregivers
Rehabilitation
Randomized Controlled Trials
Heart Failure
Exercise
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure (from BIOSTAT-CHF)
Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J. L., Chan, D. C. S., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., Hillege, H. L., Lang, C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M. & Ng, L. L., 29 Oct 2018, In : European Journal of Heart Failure. 10 p.Research output: Contribution to journal › Article
Heart Failure
Guidelines
Therapeutics
Brain Natriuretic Peptide
Confidence Intervals
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF
Ouwerkerk, W., Zwinderman, A. H., Ng, L. L., Demissei, B., Hillege, H. L., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., ter Maaten, J. M., Lang, C., van der Harst, P., Filippatos, G. S., Dickstein, K., Cleland, J. G. F., Anker, S. D. & Voors, A. A., 30 Jan 2018, In : Journal of the American College of Cardiology. 71, 4, p. 386-398 13 p.Research output: Contribution to journal › Article
Heart Failure
Biomarkers
Guidelines
Angiotensin-Converting Enzyme Inhibitors
Therapeutics
Clinical correlates and outcome associated with changes in 6-Minute Walking Distance in Patients with Heart Failure: findings from the BIOSTAT-CHF study
Ferreira, J. P., Metra, M., Anker, S. D., Dickstein, K., Lang, C., Ng, L. L., Samani, N. J., Cleland, J. G. F., van Veldhuisen, D. J., Voors, A. A. & Zannad, F., 9 Nov 2018, In : European Journal of Heart Failure.Research output: Contribution to journal › Article
Walking
Heart Failure
Proportional Hazards Models
Myocardial Ischemia
Hospitalization
Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS)
Hébert, H. L., Shepherd, B., Milburn, K., Veluchamy, A., Meng, W., Carr, F., Donnelly, L. A., Tavendale, R., Leese, G., Colhoun, H. M., Dow, E., Morris, A. D., Doney, A. S., Lang, C. C., Pearson, E. R., Smith, B. H. & Palmer, C. N. A., 1 Apr 2018, In : International Journal of Epidemiology. 47, 2, p. 380-381j 12 p.Research output: Contribution to journal › Article
Open Access
File
Prizes
American Federation of Clinical Research Trainee Investigator Award
Chim Lang (Recipient), 1994
Prize: Prize (including medals and awards)
American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award
Chim Lang (Recipient), 1995
Prize: Prize (including medals and awards)
ASEAN Congress of Cardiology Young Investigator Award
Chim Lang (Recipient), 1996
Prize: Prize (including medals and awards)
British Pharmacological Society's, BrAPP PRIZE and MEDAL.
Chim Lang (Recipient), 1993
Prize: Prize (including medals and awards)
Activities 1997 2014
“Diabetes and Heart failure: Update on research and treatment’
Chim Lang (Speaker)1 Aug 2014
Activity: Talk or presentation types › Invited talk
‘Blood pressure and heart failure: Some of the complexities of a love hate relationship.
Chim Lang (Speaker)1 Sep 2014
Activity: Talk or presentation types › Invited talk
Diabetes UK Professional Conference 2013
Chim C. Lang (Participant)13 Mar 2013 → 15 Mar 2013
Activity: Participating in or organising an event types › Participation in conference
‘Off Target Cardiovascular Effects of Diabetic Therapies’.
Chim Lang (Speaker)1 Oct 2012
Activity: Talk or presentation types › Invited talk
Diabetic heart disease
Chim Lang (Speaker)1 Mar 2009
Activity: Talk or presentation types › Invited talk
Press / Media
Diabetes drug could help reduce cardiovascular disease
22/08/16
1 media contribution
Press/Media: Research
BBC News. Type 2 diabetes drug 'could treat other conditions'
19/08/16
1 media contribution
Press/Media: Research
Type 2 diabetes drug 'could treat other conditions'
19/08/16
1 item of media coverage
Press/Media: Research
'Super-dose statins can add years to our lives,' says doctors
21/02/14
1 item of media coverage
Press/Media: Research
Thesis
Insulin resistance, chronic heart failure and potential treatment
Author: Wong, A. K. F., 2013Supervisor: Lang, C. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Medicine
File
Pharmacological modulation of insulin resistance - benefits and harms
Author: Vella, S., 2013Supervisor: Petrie, J. (Supervisor), Lang, C. (Supervisor) & Pearson, E. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Medicine
File
The Acute Effects of Allopurinol in Angina
Author: Shearer, F., 2018Supervisor: Struthers, A. (Supervisor) & Lang, C. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Medicine
File
The roles of genetics and glycaemic control in the development of LVH and Heart Failure in Type 2 Diabetes
Author: Parry, H., 2015Supervisor: Lang, C. (Supervisor) & Palmer, C. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Medicine
File